| Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib E Herraez, E Lozano, RIR Macias, J Vaquero, L Bujanda, JM Banales, ... Hepatology 58 (3), 1065-1073, 2013 | 172 | 2013 |
| Chemoresistance and chemosensitization in cholangiocarcinoma JJG Marin, E Lozano, E Herraez, M Asensio, S Di Giacomo, MR Romero, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 131 | 2018 |
| Molecular bases of the poor response of liver cancer to chemotherapy JJG Marin, O Briz, E Herraez, E Lozano, M Asensio, S Di Giacomo, ... Clinics and Research in Hepatology and Gastroenterology 42 (3), 182-192, 2018 | 85 | 2018 |
| Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development E Lozano, L Sanchez-Vicente, MJ Monte, E Herraez, O Briz, JM Banales, ... Molecular Cancer Research 12 (1), 91-100, 2014 | 85 | 2014 |
| Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology E Lozano, E Herraez, O Briz, VS Robledo, J Hernandez-Iglesias, ... BioMed research international 2013 (1), 692071, 2013 | 83 | 2013 |
| Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins E Herraez, E Gonzalez-Sanchez, J Vaquero, MR Romero, MA Serrano, ... Molecular pharmaceutics 9 (9), 2565-2576, 2012 | 79 | 2012 |
| Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours JJG Marin, MR Romero, AG Blazquez, E Herraez, E Keck, O Briz Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 9 (2), 162-184, 2009 | 70 | 2009 |
| Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds J Vaquero, O Briz, E Herraez, J Muntané, JJG Marin Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (10), 2212-2219, 2013 | 64 | 2013 |
| ACOX2 deficiency: an inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia MJ Monte, M Alonso-Peña, O Briz, E Herraez, C Berasain, J Argemi, ... Journal of hepatology 66 (3), 581-588, 2017 | 58 | 2017 |
| Genetic heterogeneity of SLC22 family of transporters in drug disposition E Lozano, O Briz, RIR Macias, MA Serrano, JJG Marin, E Herraez Journal of personalized medicine 8 (2), 14, 2018 | 55 | 2018 |
| Role of macrophages in bile acid-induced inflammatory response of fetal lung during maternal cholestasis E Herraez, E Lozano, E Poli, V Keitel, D De Luca, C Williamson, ... Journal of Molecular Medicine 92, 359-372, 2014 | 52 | 2014 |
| Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours JJG Marin, MR Romero, P Martinez-Becerra, E Herraez, O Briz Current molecular medicine 9 (9), 1108-1129, 2009 | 47 | 2009 |
| Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma JJG Marin, L Perez-Silva, RIR Macias, M Asensio, A Peleteiro-Vigil, ... Cancers 12 (8), 2116, 2020 | 46 | 2020 |
| Models for understanding resistance to chemotherapy in liver cancer JJG Marin, E Herraez, E Lozano, RIR Macias, O Briz Cancers 11 (11), 1677, 2019 | 37 | 2019 |
| Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment JJG Marin, RIR Macias, MJ Monte, E Herraez, A Peleteiro-Vigil, BS Blas, ... Cancers 12 (9), 2605, 2020 | 35 | 2020 |
| Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite M Cabello-Donayre, LM Orrego, E Herráez, P Vargas, M Martínez-García, ... Cellular and Molecular Life Sciences 77, 1827-1845, 2020 | 32 | 2020 |
| Expression of chemoresistance-associated ABC proteins in hepatobiliary, pancreatic and gastrointestinal cancers JJG Marin, MJ Monte, RIR Macias, MR Romero, E Herraez, M Asensio, ... Cancers 14 (14), 3524, 2022 | 31 | 2022 |
| Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity E Herraez, RIR Macias, J Vazquez-Tato, C Hierro, MJ Monte, JJG Marin Toxicology and applied pharmacology 239 (1), 21-28, 2009 | 22 | 2009 |
| Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity P Fernández-Tussy, R Rodríguez-Agudo, D Fernández-Ramos, ... Cell Death & Disease 12 (6), 555, 2021 | 21 | 2021 |
| Impact of alternative splicing variants on liver cancer biology JJG Marin, M Reviejo, M Soto, E Lozano, M Asensio, S Ortiz-Rivero, ... Cancers 14 (1), 18, 2021 | 19 | 2021 |
